Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
KX2-391
Cat No.
CEI-0263
Description
KX2-391 can inhibit Src with IC50 of 72 nM.
CAS No.
897016-82-9
Molecular Weight
431.53
Purity
>99%
Storage
2 years at -20 centigrade
Targets
Src
Molecular Formula
C26H29N3O3
Chemical Name
N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide
Solubility
DSMO 86 mg/mL Water
In vitro
As a small molecule and non-ATP competitive inhibitor, KX2-391 can inhibit Src tyrosine kinase signaling inhibitor with an IC50 of 72 nM by targeting the substrate binding pocket of Src. KX2-391 can also inhibit tubulin polymerization. For cell lines KX2-391 can inhibit certain leukemia cells that are resistant to current commercially available drugs, such as those derived from chronic leukemia cells with the T3151 mutation.
In vivo
In pre-clinical animal models of cancer, orally administered KX2-391 was shown to inhibit primary tumor growth and to suppress metastasis. In combination with certain chemotherapeutic agents, KX2-391 can reduce the doses of some current cytotoxic agents. KX2-391 is currently in Phase-2 testing for solid tumors.
Download
Download Datasheet